Thoracic Surgery Devices

Global Thoracic Surgery Devices Market to Reach US$981.4 Million by 2030

The global market for Thoracic Surgery Devices estimated at US$728.2 Million in the year 2024, is expected to reach US$981.4 Million by 2030, growing at a CAGR of 5.1% over the analysis period 2024-2030. Clamps, one of the segments analyzed in the report, is expected to record a 6.2% CAGR and reach US$256.0 Million by the end of the analysis period. Growth in the Forceps segment is estimated at 6.1% CAGR over the analysis period.

The U.S. Market is Estimated at US$198.4 Million While China is Forecast to Grow at 8.2% CAGR

The Thoracic Surgery Devices market in the U.S. is estimated at US$198.4 Million in the year 2024. China, the world`s second largest economy, is forecast to reach a projected market size of US$196.8 Million by the year 2030 trailing a CAGR of 8.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 2.4% and 5.1% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 3.3% CAGR.

Thoracic Surgery Devices Market Trends & Drivers Summarized

How Are Thoracic Surgery Devices Evolving to Improve Surgical Precision and Patient Outcomes?

Thoracic surgery devices are at the forefront of advancements in minimally invasive and robotic-assisted surgical procedures, significantly enhancing precision, reducing recovery times, and improving patient outcomes. These devices, which include surgical staplers, video-assisted thoracoscopic surgery (VATS) instruments, electrosurgical units, pleural drainage systems, and endoscopic suturing devices, play a crucial role in lung resections, esophageal surgeries, and procedures for thoracic malignancies. The rising global incidence of lung cancer, chronic obstructive pulmonary disease (COPD), and congenital thoracic disorders is driving the demand for advanced surgical solutions. Additionally, the growing adoption of robotic-assisted thoracic surgeries, such as da Vinci robotic procedures, is enhancing surgeon dexterity, reducing complications, and minimizing hospital stays. However, challenges such as high costs, a steep learning curve for robotic platforms, and limited access to advanced surgical technologies in developing regions continue to impact market growth. As thoracic surgery increasingly shifts toward precision and automation, how will next-generation devices revolutionize complex surgical procedures and improve long-term patient care?

What Technological Innovations Are Advancing Thoracic Surgery Devices?

Recent innovations in thoracic surgery devices are centered around improving surgical efficiency, enhancing visualization, and integrating AI-driven decision-making tools. The rise of single-port VATS and uniportal robotic-assisted surgeries is reducing surgical invasiveness while maintaining high precision. AI-powered image-guided navigation systems are enabling real-time 3D visualization of thoracic structures, helping surgeons identify and avoid critical blood vessels and nerves. The integration of energy-based sealing and cutting technologies, such as ultrasonic and radiofrequency (RF) ablation, is enhancing hemostasis and reducing operative bleeding. Additionally, smart stapling systems with real-time feedback mechanisms are ensuring optimal tissue compression and reducing anastomotic leaks in lung and esophageal surgeries. Advancements in biodegradable pleural drainage catheters and smart sensors for post-operative lung function monitoring are further streamlining patient recovery.

Why Is the Demand for Thoracic Surgery Devices Increasing?

The rising prevalence of thoracic cancers, lung infections, and pulmonary fibrosis is driving the need for advanced surgical interventions. The expansion of robotic-assisted thoracic surgery programs in hospitals, driven by the benefits of reduced post-operative complications and shorter hospital stays, is fueling demand for high-precision surgical devices. Additionally, the growing emphasis on early-stage cancer detection and minimally invasive surgical approaches is encouraging surgeons to adopt next-generation VATS and robotic platforms. The increasing availability of government funding and research grants for surgical innovation in oncology is further accelerating market adoption.

What Factors Are Driving the Growth of the Thoracic Surgery Devices Market?

The thoracic surgery devices market is expanding due to advancements in minimally invasive surgical technologies, increasing prevalence of lung diseases, rising adoption of AI-powered surgical navigation systems, and growing investments in robotic-assisted surgery. Regulatory approvals for novel surgical staplers, electrosurgical units, and VATS tools are also contributing to market expansion. As healthcare providers prioritize precision, efficiency, and patient-centered surgical care, the thoracic surgery devices industry is poised for rapid technological evolution, shaping the future of thoracic oncology and lung disease treatment.

SCOPE OF STUDY:

The report analyzes the Thoracic Surgery Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:
Product (Clamps, Forceps, Graspers, Staplers, Scissors, Spreaders, Needle Holders, Others); Surgery Type (Lobectomy, Wedge Resection, Pneumonectomy, Others); End-Use (Hospitals, Ambulatory Surgery Centers, Others)

Geographic Regions/Countries:
World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 43 Featured) -

• Abbott Laboratories
• Artivion, Inc.
• B. Braun Melsungen AG
• Becton, Dickinson and Company
• BIOTRONIK SE & Co. KG
• Boston Scientific Corporation
• Cardinal Health, Inc.
• Cardio Medical GmbH
• Dextera Surgical Inc.
• Edwards Lifesciences Corporation
• Ethicon (Johnson & Johnson)
• GE Healthcare
• Grena Ltd.
• Intuitive Surgical, Inc.
• KARL STORZ SE & Co. KG
• LivaNova PLC
• Medela AG
• Medtronic plc
• Olympus Corporation
• Richard Wolf GmbH
• Scanlan International, Inc.
• Sklar Surgical Instruments

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by artificially increasing the COGS, reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

We are diligently following expert opinions of leading Chief Economists (14,949), Think Tanks (62), Trade & Industry bodies (171) worldwide, as they assess impact and address new market realities for their ecosystems. Experts and economists from every major country are tracked for their opinions on tariffs and how they will impact their countries.

We expect this chaos to play out over the next 2-3 months and a new world order is established with more clarity. We are tracking these developments on a real time basis.

As we release this report, U.S. Trade Representatives are pushing their counterparts in 183 countries for an early closure to bilateral tariff negotiations. Most of the major trading partners also have initiated trade agreements with other key trading nations, outside of those in the works with the United States. We are tracking such secondary fallouts as supply chains shift.

To our valued clients, we say, we have your back. We will present a simplified market reassessment by incorporating these changes!

APRIL 2025: NEGOTIATION PHASE

Our April release addresses the impact of tariffs on the overall global market and presents market adjustments by geography. Our trajectories are based on historic data and evolving market impacting factors.

JULY 2025 FINAL TARIFF RESET

Complimentary Update: Our clients will also receive a complimentary update in July after a final reset is announced between nations. The final updated version incorporates clearly defined Tariff Impact Analyses.

Reciprocal and Bilateral Trade & Tariff Impact Analyses:

USA
CHINA
MEXICO
CANADA
EU
JAPAN
INDIA
176 OTHER COUNTRIES.

Leading Economists - Our knowledge base tracks 14,949 economists including a select group of most influential Chief Economists of nations, think tanks, trade and industry bodies, big enterprises, and domain experts who are sharing views on the fallout of this unprecedented paradigm shift in the global econometric landscape. Most of our 16,491+ reports have incorporated this two-stage release schedule based on milestones.

Please note: Reports are sold as single-site single-user licenses. Electronic versions require 24-48 hours as each copy is customized to the client with digital controls and custom watermarks. The Publisher uses digital controls protecting against copying and printing is restricted to one full copy to be used at the same location.

The latest version of Adobe Acrobat Reader is required to view the report. Upon ordering an electronic version, the Publisher will provide a link to download the purchased report.

Prior to fulfillment of an order, the client will be required to sign a document detailing the purchase terms for a publication from this publisher.